HSD17B13-IN-37 (78) serves as an inhibitor for 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting potency with an IC 50 of less than 0.1 μM against Estradiol. This compound is utilized in the study of NAFLD (Nonalcoholic fatty liver diseases) [1].